Canlyniadau Chwilio - Nikeith John
- Dangos 1 - 3 canlyniadau o 3
-
1
<sup>177</sup>Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing<sup>177</sup>Lu-PSMA-I&T Therapy gan Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker, William Counter, Bao Ho, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Aron Poole, Adam Hickey, Shikha Agrawal, G. Perkins, Annukka Kallinen, Enid M. Eslick, Martin R. Stockler, Anthony M. Joshua, Andrew Nguyen, Louise Emmett
Cyhoeddwyd 2022Artigo -
2
Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT) gan Louise Emmett, Nikeith John, Sarennya Pathmanandavel, William Counter, Maria Ayers, Shikha Sharma, Shikha Agrawal, Aron Poole, Elizabeth Hovey, Ganes Pranavan, Craig Gedye, Girish Mallesara, Alex Guminski, Adrian V. Lee, Martin R. Stockler, Adam Hickey, Peter Eu, Anthony M. Joshua, Megan Crumbaker, Andrew Nguyen
Cyhoeddwyd 2023Artigo -
3
Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database gan Louise Emmett, Nathan Papa, William Counter, Jérémie Calais, Francesco Barbato, Irene A. Burger, Matthias Eiber, Matthew J. Roberts, Shikha Agrawal, Anthony Franklin, Alan Xue, Krishan Rasiah, Nikeith John, Daniel Moon, Mark Frydenberg, John Yaxley, Phillip D. Stricker, Keith Wong, Geoff Coughlin, Troy Gianduzzo, Boon Kua, Bao Ho, Andrew Nguyen, Victor Liu, Jonathan Lee, Edward Hsiao, Tom Sutherland, Elisa Perry, Wolfgang P. Fendler, Thomas A. Hope
Cyhoeddwyd 2023Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Cancer
Internal medicine
Medicine
Nuclear medicine
Prostate cancer
Interquartile range
Prostate-specific antigen
Urology
Biopsy
Chemotherapy
Confidence interval
Mathematics
Multiparametric MRI
Oncology
Overall survival
Progression-free survival
Progressive disease
Prostate
Prostate biopsy
Radiology
Reproducibility
Response Evaluation Criteria in Solid Tumors
Statistics